UCB Biopharma SRL has a total of 295 patent applications. It increased the IP activity by 468.0%. Its first patent ever was published in 2007. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are ICHNOS SCIENCES S A, DEV CENTER BIOTECHNOLOGY and ADAMED SP ZO O.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 70 | |
#2 | United States | 45 | |
#3 | Australia | 26 | |
#4 | Canada | 22 | |
#5 | WIPO (World Intellectual Property Organization) | 21 | |
#6 | Brazil | 17 | |
#7 | United Kingdom | 17 | |
#8 | Israel | 17 | |
#9 | Republic of Korea | 16 | |
#10 | Singapore | 12 | |
#11 | Hungary | 6 | |
#12 | Chile | 5 | |
#13 | Colombia | 5 | |
#14 | Serbia | 5 | |
#15 | EAPO (Eurasian Patent Organization) | 3 | |
#16 | Ecuador | 3 | |
#17 | Peru | 2 | |
#18 | Argentina | 1 | |
#19 | China | 1 | |
#20 | Montenegro | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Computer technology | |
#6 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Heterocyclic compounds | |
#5 | Analysing materials | |
#6 | Microorganisms | |
#7 | Separation | |
#8 | Organic chemistry methods | |
#9 | Image data processing | |
#10 | Healthcare informatics |
# | Name | Total Patents |
---|---|---|
#1 | Baker Terence Seward | 39 |
#2 | Tyson Kerry Louise | 29 |
#3 | Zhu Zhaoning | 25 |
#4 | Downey Patrick | 25 |
#5 | Mcmillan David James | 25 |
#6 | Lightwood Daniel John | 24 |
#7 | De Lichtervelde Lorenzo | 18 |
#8 | Adams Ralph | 18 |
#9 | Provins Laurent | 17 |
#10 | Heer Jag Paul | 17 |
Publication | Filing date | Title |
---|---|---|
GB202102227D0 | Antibodies | |
GB202100737D0 | Binding molecules | |
GB202018889D0 | Formulations | |
GB202018250D0 | Formulations | |
GB202018251D0 | Formulations | |
GB202017640D0 | Therapeutic agents | |
GB202017642D0 | Therapeputic agents | |
GB202017641D0 | Therapeutic agents | |
GB202016386D0 | Binding molecules | |
WO2021032687A1 | Antimalarial hexahydropyrimidine analogues | |
GB202012481D0 | Therapeutic agents | |
WO2021023619A1 | Methods for purifying antibodies | |
WO2021001286A1 | A substituted tetrahydroisoquinoline derivative as a d1 positive allosteric modulator | |
GB202009912D0 | Therapeutic agents | |
WO2021001288A1 | A substituted tetrahydroisoquinoline derivative as a d1 positive allosteric modulator | |
WO2020254483A1 | Hplc-based detection of flocculation agents in a protein sample | |
WO2020221737A1 | Medical image analysis system and method for identification of lesions | |
GB202005153D0 | Therapeutic agents | |
GB202002636D0 | Therapeutic agents | |
GB202002635D0 | Therapeutic agents |